Drug eluting stents are safe for licensed indications, FDA panel saysBMJ 2006; 333 doi: http://dx.doi.org/10.1136/bmj.39063.481285.DB (Published 14 December 2006) Cite this as: BMJ 2006;333:1235
- Susan Mayor
Drug eluting stents (DES) are safe when used within their licensed indications, a panel of the US Food and Drug Administration advised at a special meeting last week. But the possibility that stents may be associated with increased risk of death and myocardial infarction caused by late stent thrombosis when used off label should be investigated further, it says.
The panel suggested that the increased risk may be related to use of antiplatelet therapy for too short a time in higher risk patients and …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial